Green Cross Medical Science Corporation (142280) — Cash Flow Reinvestment Rate
Green Cross Medical Science Corporation (142280) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting ₩460.89 Million (capex ₩460.89 Million ) from operating cash flow of ₩5.01 Billion. Check Green Cross Medical Science Corporation earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Green Cross Medical Science Corporation Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Green Cross Medical Science Corporation across 6 annual periods. Explore 142280 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Green Cross Medical Science Corporation (2016–2025)
Year-by-year capital reinvestment analysis for Green Cross Medical Science Corporation. For live market cap and broader valuation context, see 142280 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | ₩4.90 Billion | ₩7.20 Billion | ₩4.90 Billion | ▼ -61.5% |
| 2024 | 1.77x | ₩6.47 Billion | ₩3.66 Billion | ₩3.22 Billion | ▼ -20.7% |
| 2023 | 2.23x | ₩9.45 Billion | ₩4.24 Billion | ₩5.63 Billion | ▲ +311.2% |
| 2022 | 0.54x | ₩5.90 Billion | ₩10.88 Billion | ₩3.43 Billion | ▼ -0.8% |
| 2017 | 0.55x | ₩1.70 Billion | ₩3.11 Billion | ₩1.11 Billion | ▲ +106.8% |
| 2016 | 0.26x | ₩2.71 Billion | ₩10.25 Billion | ₩1.89 Billion | — |